↓ Skip to main content

Dove Medical Press

Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety

Overview of attention for article published in Therapeutics and Clinical Risk Management, April 2021
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (55th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy
1 policy source

Citations

dimensions_citation
5 Dimensions

Readers on

mendeley
23 Mendeley
Title
Budesonide MMX in the Treatment of Ulcerative Colitis: Current Perspectives on Efficacy and Safety
Published in
Therapeutics and Clinical Risk Management, April 2021
DOI 10.2147/tcrm.s263835
Pubmed ID
Authors

Giovanni Maconi, Deborah Camatta, Rosanna Cannatelli, Francesca Ferretti, Anna Carvalhas Gabrielli, Sandro Ardizzone

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Other 3 13%
Student > Ph. D. Student 2 9%
Student > Postgraduate 2 9%
Student > Master 2 9%
Professor 1 4%
Other 2 9%
Unknown 11 48%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 5 22%
Medicine and Dentistry 3 13%
Biochemistry, Genetics and Molecular Biology 2 9%
Unknown 13 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 October 2023.
All research outputs
#8,541,797
of 25,387,668 outputs
Outputs from Therapeutics and Clinical Risk Management
#462
of 1,323 outputs
Outputs of similar age
#183,755
of 453,673 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#9
of 19 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 55% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 453,673 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.
We're also able to compare this research output to 19 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.